Action from Insight

We are passionate about developing innovative, ground-breaking tests, products and tools to enhance patient care, provide value to our clients, and transform information into knowledge and insights.

Click on a topic to see our innovations for each

Diagnostic Services

  • Cancer
    ColoVantage®: the first blood test to aid the detection of colorectal cancer in patients non-adherent to current testing approaches.
  • Cancer
    First to offer breakthrough ovarian cancer tests.
  • General Health
    ImmunoCAP® allergy testing benefits both patients and physicians with easier testing.
  • Genetics
    Pioneer in pharmacogenomic testing to personalize medicine.
  • Genetics
    The XSense® test: Fragile X Syndrome test for autism and mental retardation using faster molecular technology.
  • Neurology
    Our Variant Investigation Team is dedicated to helping you confirm clinical diagnoses.
  • Neurology
    CogniSense™, the new iPad-based assessment, provides a new vital statistic: your cognitive score.
  • Infectious Diseases
    We're known for being first to introduce new emerging disease diagnostics to the market.
  • Infectious Diseases
    Type-specific HSV testing
  • Cancer
    Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service.
  • Cancer
    Elevating the standard of care for breast cancer patients.
  • Cardiovascular
    Cardio CRP® helps physicians identify patients at risk for cardiovascular-related disorders, including coronary events.
  • Cardiovascular
    Going beyond the standard cholesterol tests.
  • Cardiovascular Disease / Genetics
    The LPA-Aspirin Genotype test helps predict cardiovascular disease risk and response to aspirin therapy.
  • Cardiovascular Disease / Genetics
    Predicting the risk for early heart attacks.
  • Genetics
    Our Quest Diagnostics Genetics Center is at the forefront of genetic testing.
  • Quality
    Leading the charge to raise the quality of healthcare delivery.
  • Secondary Consult
    Our medical staff consults on test selection and rare or complex testing.
  • Endocrinology
    More than 100 endocrine assays developed over more than 40 years.
  • Infectious Diseases
    The HIV-1 Coreceptor Tropism Test helps physicians identify patients suitable for the latest class of HIV therapies.
  • Specimen Tracking
    First national lab to provide healthcare professionals easy access to track a specimen in real-time.

Data Diagnostics

  • Data Diagnostics ®
    Drive value throughout your organization with Data Diagnostics®, a solution from the Quanum portfolio that delivers actionable insights at the point of care.

Patient Services

  • Cardiovascular
    Personalized care to help improve and maintain heart health.
  • Specimen collection
    Making blood draws more comfortable—for children and adults!
  • MyQuest™ Patient Portal
    The MyQuest patient portal and free mobile app empower patients to take control of their health.
  • Appointment Scheduling
    Industry's first national patient appointment-scheduling system.
  • Reminders
    Reminder services to help patients manage their health and remember the lab testing recommended by their doctor.

Healthcare Information Technology

  • Certified EHR Technology
    Quanum EHR delivers the full clinical encounter documentation capabilities that physicians want with easy integration.
  • Mobile Access
    Take your office wherever you go with Quanum HD for the iPad® available to all Quanum customers.
  • Document Management
    ChartMaxx ECM: Better Decisions with Real-Time Collaboration

Risk Assessment and Wellness

  • Informatics
    Health Trends™ Across America: providing insights on the state of the nation's health.
  • Informatics
    The benchmark for workplace drug-use measurement.
  • Driving Participation
    Unique laboratory-based wellness program helps reduce healthcare spending and costs.
Cancer

ColoVantage®: the first blood test to aid the detection of colorectal cancer in patients non-adherent to current testing approaches.

Colon cancer is the second leading cause of cancer deaths in the United States, but is often treatable when caught in early stages. Sixty percent of colon cancer deaths could be prevented if people were screened as indicated by guidelines, according to the U.S. Centers for Disease Control and Prevention. However, nearly one in three men and women age 50 and over have not been screened. Quest Diagnostics introduced ColoVantage®, a blood test that detects methylated DNA from the Septin 9 gene, a marker for colorectal cancer, that can help with detection of colorectal cancer in patients that have avoided established colorectal cancer screening tests such as colonoscopy, fecal occult blood tests, and fecal immunochemical tests (FITs). ColoVantage is not a replacement test for colonoscopy.

Cancer

First to offer breakthrough ovarian cancer tests.

Ovarian cancer is the leading cause of death from gynecologic cancers in the U.S. and the fifth-leading cause of cancer deaths in women. Ovarian masses affect approximately one million women and lead to as many 300,000 ovarian mass surgeries in the U.S. each year. Quest Diagnostics is the only national lab to offer FDA-cleared OVA1™ test. The OVA1™ Test is a qualitative serum test that combines the results of five immunoassays into a single numerical result. It is indicated for women who meet the following criteria: over age 18, ovarian adnexal mass present for which surgery is planned, and not yet referred to an oncologist. The OVA1™ Test is an aid to further assess the likelihood that malignancy is present when the physician's independent clinical and radiological evaluation does not indicate malignancy. The test is not intended as a screening or stand-alone diagnostic assay.

PRECAUTION: The OVA1™ Test should not be used without an independent clinical/radiological evaluation and is not intended to be a screening test or to determine whether a patient should proceed to surgery. Incorrect use of the OVA1™ Test carries the risk of unnecessary testing, surgery, and/or delayed diagnosis.

A negative OVA1™ Test result, in the setting of a positive pre-surgical assessment, should not preclude oncology referral. The OVA1™ Test is not indicated for patients with a diagnosis of malignancy within the last 5 years.

General Health

ImmunoCAP® allergy testing benefits both patients and physicians with easier testing.

More than 50 million people in the U.S. have allergies. An essential step for providing the right treatment for these patients is to determine what is causing the allergy. The ImmunoCAP® test identifies hundreds of specific allergens with only a single blood sample. Among allergy blood tests ImmunoCAP is widely considered to be the most precise and reliable, with performance comparable to skin prick testing. However, unlike skin prick testing, ImmunoCAP does not require the patient to stop taking antihistamines or pose a risk of severe allergic reaction.

Genetics

Pioneer in pharmacogenomic testing to personalize medicine.

Our AccuType® tests help predict a patient's response to certain drugs so that healthcare providers can select appropriate treatment for each patient's needs. Our AccuType® CP test is the first cardiovascular disease test to identify a patient's response to Plavix® (clopidogrel bisulfate). This anti-clotting drug is often prescribed to prevent heart attacks or strokes and is the second best-selling drug in the world. The AccuType® family also includes tests to help predict response related to warfarin, tamoxifin, therapies for hepatitis C virus, and others.

Genetics

The XSense® test: Fragile X Syndrome test for autism and mental retardation using faster molecular technology. The test is highly accurate, and may be suitable for high-volume population screening and diagnostic testing on a range of patients, including women and newborns.

Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism. Physicians can use Xsense® to aid their identification of women who, as carriers, may be unaffected or slightly affected by Fragile X syndrome, but are at risk of passing it to offspring, regardless of the father's genetics. XSense employs a laboratory analysis technique that bypasses the need to perform the Southern Blot DNA analysis method in 99 percent of cases. Xsense is an accurate, faster testing option with results reported in about a week for the vast majority of patients.

Neurology

Our Variant Investigation Team is dedicated to helping you confirm clinical diagnoses.

We know how frustrating it can be to receive test results that read "variables of unknown significance." The Athena Insight™ Variant Investigation Program gives you access to the information you need to clarify result significance. Our detailed service reports are easy to interpret and understand. Additionally, our team of genetic counselors and lab directors provides expert consultative services on each case, giving you deeper insight and answering technical questions. Our goal is to help you make more informed patient management decisions.

NEUROLOGY

CogniSense™, the new iPad-based assessment, provides a new vital statistic: your cognitive score.

It provides physicians and patients with a cognitive score which can be monitored over time. It’s easy to use, too. The iPad platform allows a certified health care provider to administer the test in about 10 minutes. Results are then securely sent to Quanum and other supported EMRs. Performing a cognitive test has never been easier. To learn more or to  download CogniSense™, visit QuestCogniSense.com.

Infectious Diseases

We're known for being first to introduce new emerging disease diagnostics to the market.

We develop innovative tests and products to assist physicians in diagnosing infectious diseases, and often provide the first diagnostic tests in the U.S. for emerging diseases, such as West Nile Virus, SARS, Lyme disease and Influenza A H1N1 (2009).

Cancer

Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS, NRAS, and BRAF Gene Mutations in Reflex Testing Service.

The EGFR Pathway Test analyzes in sequential reflex fashion more mutations potentially inhibiting anti-EGFR therapy response in metastatic colorectal cancer patients.

Periodontal Disease

OralDNA® Labs offers salivary DNA tests that can be administered chairside.

The MyPerioPath® salivary diagnostic test identifies the type and concentration of specific perio-pathogenic bacteria that are known to cause periodontal disease. MyPerioPath® helps support the clinician with better risk assessment and personalized treatment options for more predictable outcomes.

Cancer

Elevating the standard of care for breast cancer patients.

We have pioneered tools to aid in the battle against invasive breast cancer, the most frequently diagnosed cancer in women in the U.S. and the second leading cause of cancer-related death. Test offerings include ER/PR/HER2 testing and tests to detect breast cancer recurrence/metastasis and monitor therapeutic response. The CellSearch® test for circulating tumor cells helps physicians monitor and predict cancer progression, and evaluate response to therapy in patients with metastatic breast cancer.

Cardiovascular

Cardio CRP® helps physicians identify patients at risk for cardiovascular-related disorders, including coronary events.

Above-normal levels are a strong indicator for future cardiovascular-related disorders, including heart attack. The Cardio CRP® blood test can help physicians identify at-risk patients in order to recommend appropriate medical or lifestyle interventions.

Cardiovascular

Going beyond the standard cholesterol tests.

Patients whose LDL cholesterol (low-density lipoproteins, also known as the "bad" cholesterol) is mostly made up of small, dense particles have a greater risk of cardiovascular disease. Small LDL particles cause plaque to build up faster because they enter the artery wall more easily than large LDL particles. Our Gradient Gel Electrophoresis Test is the first to provide direct, physical measurement of lipoprotein particles, which can help physicians assess patients' risk for heart attack and other cardiovascular problems.

Cardiovascular Disease / Genetics

The LPA-Aspirin Genotype test helps predict cardiovascular disease risk and response to aspirin therapy.

The information provided by the test may help physicians assess the potential cardiovascular benefit of aspirin compared to the bleeding risk it may pose, and reduce risk through personalized genotyping.

Cardiovascular Disease / Genetics

Predicting the risk for early heart attacks.

The 9p21 Genotyping Test provides genetic information about a patient's risk for a heart attack at an early age (women before the age of 60 and men before 50), as well as other cardiovascular problems. Knowing a patient's 9p21 genetic risk can help the physician and patient take steps to reduce other risk factors that cause cardiovascular disease development and progression.

Genetics

Our Quest Diagnostics Genetics Center is at the forefront of genetic testing.

Prenatal genetic testing can help identify the small number of women whose babies are at risk for certain birth defects. Our Maternal Serum Screen 5 (Penta Screen) blood test is used to assess risk for neural tube defects, which affect the spinal column or brain. The Penta Screen also helps assess risk for Down syndrome and Trisomy 18, both of which can cause mental retardation. For physicians requiring assistance with prenatal screening results, we offer consultations with board-certified scientific and medical directors, genetic counselors and academic associates.

Quality

Leading the charge to raise the quality of healthcare delivery.

Quality is not just our commitment. It's our passion. We were the first healthcare services company in the U.S. to commit to striving to achieve "virtual perfection" – consistently high quality – through Six Sigma. Six Sigma is a rigorous, data-centered approach that helps organizations prevent problems by building quality directly into their processes. Through the Six Sigma method, we are driving quality as well as reducing costs.

Secondary Consult

Our medical staff consults on test selection and rare or complex testing.

With approximately 900 industry-leading MDs and PhDs across the organization, we have the unsurpassed scientific expertise and broad therapeutic experience to provide leadership and consultative services.

Endocrinology

More than 100 endocrine assays developed over more than 40 years.

We have provided state-of-the-art endocrine testing for more than four decades and offer the industry's most comprehensive endocrinology diagnostic menu. Specialists rely on our broad test offering when treating patients with complex clinical conditions. Areas of clinical focus include diabetes, thyroid disease, adrenal dysfunction, reproduction, bone / mineral / metabolism, pediatric endocrinology, and Vitamin D testing.

Infectious Diseases

The HIV-1 Coreceptor Tropism Test helps physicians identify patients suitable for the latest class of HIV therapies.

The HIV-1 Coreceptor Tropism Test, which reports results in approximately half the time of the nearest competing test, helps physicians determine whether a patient with a history of HIV drug resistance will respond to the latest class of HIV antiretroviral therapies. The test provides physicians with timely information so they may more quickly determine or change therapy based on how the HIV virus infects the patient's cells.

Infectious Diseases

Type-specific HSV testing

There are approximately one million new cases of genital herpes each year in the U.S. Type-specific HSV testing is used to help diagnose herpes and to distinguish between the two types of herpes infection – HSV-1 and HSV-2. Because HSV-2 leads to more frequent symptom recurrence than HSV-1, it poses a higher risk of transmission to sexual partners. It is also linked to an increased risk of acquiring and transmitting HIV infection. The test result can help guide the physician towards the appropriate choice of treatment and patient counseling.

General Health

Quest Diagnostics wins gold Medical Design Excellence Award (MDEA) for diagnostic innovation.

Timely decision making by physicians can be vital to patient outcomes. Simplexa® test kits on the 3M Integrated Cycler bring high-end PCR testing nearer patients, where timely decision making can impact patient outcomes. Simplexa molecular diagnostic test on the 3M® Integrated Cycler won a gold award in the in vitro diagnostics category at the 2011 MDEA awards, underscoring our commitment to developing industry-leading diagnostics that will improve patient care.

In April 2011, the Simplexa/3M technology also won a bronze 2011 Edison Award (Science & Medical category; Diagnostic Aids segment). The award is based on criteria that included technological innovation and marketplace success."

Infectious Diseases

First laboratory-developed test for West Nile Virus.

Our Quest Diagnostics Infectious Disease laboratory was the first lab to develop a test for West Nile Virus after it was identified in New York in 1999. Infected mosquitoes spread the virus, which in rare cases can lead to severe complications or death.

Infectious Diseases

Type-specific HSV testing

There are approximately one million new cases of genital herpes each year in the U.S. Type-specific HSV testing is used to help diagnose herpes and to distinguish between the two types of herpes infection – HSV-1 and HSV-2. Because HSV-2 leads to more frequent symptom recurrence than HSV-1, it poses a higher risk of transmission to sexual partners. It is also linked to an increased risk of acquiring and transmitting HIV infection. The test result can help guide the physician towards the appropriate choice of treatment and patient counseling.

Cardiovascular

Personalized care to help improve and maintain heart health.

The 4myheart® Program provides personalized care to help patients improve their cardiac health. A clinical educator addresses the patient's risk for heart disease and stroke, using the test results and a treatment plan from the patient's doctor. The 4myheart Program provides a personal touch through individual and group education, and many patients have seen impressive results in terms of cardiovascular risk reduction.

Specimen collection

quiggles™ wiggles, but you shouldn't!

quiggles helps make blood draws more comfortable and less stressful for children and patients of all ages. This phlebotomy device features a soothing combination of ice pack and vibration. This makes the draw feel more comfortable — for everyone, including little ones, their parents, and adults alike!

Data Diagnostics®

A Quanum solution: Insights health systems need to promote efficient coordination of quality care

Today’s healthcare environment is driven by data to improve clinical and quality outcomes, achieve cost efficiencies, and help enhance financial performance. Data Diagnostics is a suite of patient-specific, real-time analytics that can be accessed on demand by clinicians at the point of care within their existing workflow.

Mobile Access

The MyQuest™ patient portal and free mobile app empower patients to take control of their health.

As a trusted provider of diagnostic testing, we're committed to delivering solutions for patients to securely manage their health. That's why we created MyQuest, our patient portal and free mobile app that enable users to receive lab results and manage health information such as medications and emergency contacts. With MyQuest, users can see, store and share their vital health information with ease and security on the go.

Specimen Tracking

First national lab to provide healthcare professionals easy access to track a specimen in real-time.

Specimen Status Tracking provides transparency, empowering healthcare professionals to better manage their patients and move their care forward. Specimen Status Tracking is available through QuestConnect ™, and allows providers to see whether a patient was compliant with lab testing, and follow the patient’s specimen through every step of its journey to and through our laboratory.

Appointment Scheduling

Industry's first national patient appointment-scheduling system.

We launched the first national patient appointment-scheduling system in the diagnostic testing service industry. This easy-to-use, Web-based system lets patients conveniently schedule their appointments at our testing centers.

Reminders

Three distinct reminder services to help patients manage their health and remember the lab testing recommended by their doctor.

We understand how challenging it can be to get through the daily to-do list. That's why we've created:

  • Health & Wellness Email Reminders: For a reminder to schedule an annual health checkup.
  • Pregnancy Health Reminders: For timely information about important lab tests and helpful tips related to pregnancy.
  • TestMinder®: Reminders for patients undergoing frequent testing, such as when their physician is monitoring a condition or medication use.

Certified EHR Technology

Used by more than 200,000 physicians in 80,000 physician offices nationwide, Quanum EHR delivers the full clinical encounter documentation capabilities that physicians want with easy integration.

As an ONC-ATCB -certified solution*, Quanum EHR allows physicians to complete a wide range of patient-care-centered clinical tasks right at the point of care, including:

  • Electronic lab management
  • ePrescribing
  • Clinical messaging
  • Clinical documentation tools
  • Document management
  • Multisystem interoperability
  • Remote and Secure Capabilities
  • Certified for Meaningful Use
  • Up and Running in Weeks
Mobile Access

Take your office wherever you go with Quanum HD for the iPad® available to all Quanum customers.

Log onto your virtual desk to view and take action on lab results, prescription requests (ePrescribing) and clinical notes. Ideal for when you're on call or on the go, this free* HIPAA-compliant app allows you to easily access your patient records anywhere, anytime.*

*Quanum subscription required to use Quanum HD. Features available depend on your subscription.

Document Management

ChartMaxx ECM: Better Decisions with Real-Time Collaboration

ChartMaxx® Enterprise Content Management (ECM) is a key component of ChartMaxx, the award-winning document management and imaging (DMI) solution. The features and functionality of ChartMaxx ECM allow for better and quicker decision making, flexible and real-time collaboration and the ability to define and refine dynamic processes that reach across hospital systems and departments.

Informatics

Health Trends™ Across America: providing insights on the state of the nation's health.

With more than 1.1 billion patient encounters since 2000, we maintain the largest private clinical laboratory data repository in the U.S. Quest Diagnostics Health Trends™ reports identify and track disease and wellness benchmarks. They are made available as a public service to inform patients, healthcare professionals and policy makers about the current state of the nation's health. Our Health Trends™ reports include allergies, diabetes, heart health, H1N1 influenza A, kidney disease and more.

Informatics

The benchmark for workplace drug-use measurement.

The Drug Testing Index™ is the industry standard for measuring and reporting workforce drug use. The Index summarizes results compiled from workplace drug tests performed exclusively by Quest Diagnostics. Published semi-annually as a public service for government, media and industry, the Index is widely viewed as a benchmark for national trends.

Driving Participation

Unique laboratory-based wellness program helps reduce healthcare spending and costs.

Laboratory results can reveal hidden health risks and help to motivate healthy behavior change. Available to employers as well as individuals, our Blueprint for Wellness is a unique lab-based approach to wellness. Blueprint for Wellness is a personal health assessment based on laboratory test results and/or information from a health questionnaire. Our laboratory insights provide measurable results that help participants manage risk more effectively, in turn reducing healthcare spending and costs.